Skip to main content
Premium Trial:

Request an Annual Quote

Mixed Bag for Life Science Tool Stocks in December

NEW YORK (GenomeWeb News) – While many of the stocks of the life science tool vendors that comprise the GenomeWeb Daily News Index continued their losses for the month of December, the Index finally rebounded to positive growth after three straight months of declines.
 
The Index, which now includes 36 firms following the inclusion of three new entries this month — Monogram Biosciences, Myriad Genetics, and Pressure BioSciences — gained 1 percent for the month of December. That followed consecutive drops of 9 percent, 22 percent, and 9 percent for September, October, and November, respectively.
 
In comparison, the Dow Jones Industrial Average dipped .6 percent, while the Nasdaq rose around 3 percent, and the Nasdaq Biotech Index posted a strong gain of 8 percent for the month.
 
Two of the new entries into the Index were the highest gainers for December. Monogram’s shares rose 31 percent, while Pressure Bio’s shares shot up 46 percent. However, since trading in the $4 to $5 range earlier in the year, Pressure Bio’s shares have fallen to a range of $.55 to $1.15 over the past month. Myriad Genetics, the other new member of the Index, gained around 12 percent for December.
 
Other firms that posted significant increases in December were Sequenom (+19 percent), Illumina (+18 percent), and Gen-Probe (+16 percent).
 
Rosetta Genomics suffered the steepest loss in share price for the month, dropping 46 percent, while Helicos BioSciences’ difficulties continued with a decline of 44 percent.
 
Rosetta’s sinking stock has happened just as the firm has rolled out its initial microRNA-based diagnostic products. The firm expects that the first three of these tests will generate revenues of between $5 million and $9 million in 2009.
 
Early in the month, Helicos announced plans to reduce its workforce by approximately 30 percent in a bid to cut costs. Then a couple of weeks ago, it said that it had signed a definitive agreement with certain investors to raise gross proceeds of around $18.6 million through a private placement of the firm’s shares, infusing the company with some needed cash.
 
While GenomeWeb Daily News covers many more firms than the 36 that are in the Index, those that have been included have a significant portion of their business focused on molecular biology and cellular analysis tools and/or molecular diagnostics, and are publicly traded in the US.

 
GenomeWeb Daily News Index
Company
Ticker
Current Price
(Dec. 31, 2008)
Last
Price
(Nov. 28, 2008)
% change
Accelrys
ACCL
4.36
3.90
11.79
Accelr8
AXK
2.30
2.50
-8.00
Affymetrix
AFFX
2.99
2.74
9.12
Agilent
A
15.63
18.83 
-16.99
Beckman
BEC
43.94
43.58
0.83
Becton Dickinson
BDX
68.39
63.53
7.65
Bio-Rad
BIO
75.31
74.16
1.55
Bruker
BRKR
4.04
4.70
-14.04
Caliper
CALP
0.97
1.13
-14.16
Celera
CRA
11.13
9.74
14.27
Cepheid
CPHD
10.38
13.58
-23.56
Clinical Data
CLDA
8.90
9.50
-6.32
CombiMatrix
CBMX
7.00
7.34
-4.63
Compugen
CGEN
0.43
0.60
-28.33
DeCode Genetics
DCGN
0.19
0.24
-22.92
Genomic Health
GHDX
19.48
18.53
5.13
Gen-Probe
GPRO
42.84
36.85
16.26
Helicos BioSciences
HLCS
0.39
0.70
-44.29
Illumina
ILMN
26.05
22.01
18.36
Life Technologies
LIFE
23.31
26.10
-10.69
Luminex
LMNX
21.36
22.01
-2.95
MDS
MDZ
6.13
7.04
-12.93
Millipore
MIL
51.52
50.66
1.70
Monogram Biosciences
MGRM
2.60
1.98
31.31
Myriad Genetics
MYGN
66.26
59.28
11.77
Nanogen
NGEN
0.14
0.17
-17.65
Nanosphere
NSPH
4.76
5.00
-4.80
Orchid Cellmark
ORCH
0.67
0.86
-22.09
PerkinElmer
PKI
13.91
18.06
-22.98
Pressure BioSciences
PBIO
1.05
0.72
45.83
Qiagen
QGEN
17.56
16.13
8.87
Rosetta Genomics
ROSG
1.18
2.17
-45.62
Sequenom
SQNM
19.84
16.71
18.73
Sigma-Aldrich
SIAL
42.24
43.11
-2.02
Thermo
TMO
34.07
35.68
-4.51
Waters
WAT
36.65
41.23
-11.11
GWDN Index Average
19.11
18.92
1.01
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.